Clinical Trials Browser

Phase 2 × Recurrence × Panitumumab × Clear all

NCT00454779 2018-10-17

PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response

Phase 2 Completed

113 enrolled 18 charts

Neoplasm Metastasis, Recurrence

NCT01388621 2013-08-20

PROVE

Phase 2 Unknown

Ovarian Neoplasms, Recurrence